LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.74 USD Market Closed
Market Cap: 45.8m USD

Wall Street
Price Targets

LVTX Price Targets Summary
LAVA Therapeutics NV

There are no price targets for LVTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
LAVA Therapeutics NV Competitors:
Price Targets
CANTA
Cantargia AB
91% Upside
NIOX
Niox Group PLC
27% Upside
ALXO
ALX Oncology Holdings Inc
159% Upside
XFOR
X4 Pharmaceuticals Inc
104% Upside
2616
CStone Pharmaceuticals
146% Upside
TNG
Transgene SA
59% Upside
ELDN
Eledon Pharmaceuticals Inc
383% Upside
IMMX
Immix Biopharma Inc
147% Upside

Revenue
Forecast

Revenue Estimate
LAVA Therapeutics NV

For the last 4 years the compound annual growth rate for LAVA Therapeutics NV's revenue is 36%.

36%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
LAVA Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
LAVA Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LVTX's stock price target?
Not Available

LVTX doesn't have any price targets made by Wall Street professionals.

Back to Top